22 November 2016 EMA/HMPC/114746/2017 Inspections, Human Medicines Pharmacovigilance & Committees Division
Work plan for the HMPC Quality Drafting Group (Q DG) 2017
Chair
Status
L. Anderson
Final
1. Meetings scheduled for 2017 Meeting dates: 23-24 February (face-to-face), 20 April, 28 June, 7 September, 19 October and 7 December. One face-to-face meeting will be organised in February 2017, other meetings will be held virtually.
2. New guidance documents •
Guidance on the use of new analytical methods for the quality control of herbal medicinal products. Action: Publication of reflection paper for public consultation and proposal for follow-up such as Q&A.
•
Guidance on the control of pyrrolizidine alkaloids in herbal medicinal products. Action: Check existing guidance documents (including GACP and specification guideline) for necessary updates and initiate subsequent revisions and/or draft transitionally Q&A.
3. Update, extension or revision of existing guidance documents •
Revision of the Guideline on quality on herbal medicinal products. Action: Publication of the draft revised GL for consultation after coordination with QWP/CHMP and CVMP).
•
Revision of the Guideline on specifications: test procedures and acceptance criteria for herbal substances, herbal preparations and HMP/THMPs.
30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact
Action: Publication of the draft revised GL for consultation after coordination with QWP/CHMP and CVMP). •
Update/revision of questions & answers on quality of herbal medicinal products (EMA/HMPC/41500/2010). Action: (1) review and add new Q&A following quality assessors training 2015 (skip testing, stability, GACP/GMP, assay and markers; microbiological issues), and reflection paper on microbiological aspects; (2) check for redundant Q&A taken into revised guidelines (quality, specifications) and reduce accordingly.
•
Review and update of the Guideline on declaration of herbal substances / preparations in (T)HMP. Action: Review for necessary updates and publication of correction if minor or publish concept paper for start of revision if major.
•
Review of the Reflection paper on markers used for quantitative and qualitative analysis of herbal medicinal products and traditional herbal medicinal products. Action: Review for suitability vis-a-vis Ph. Eur. definitions and HMPC monographs/ assessment reports with focus on definitions for active markers and markers with known therapeutic activity (in coordination with MLWP).
4. Coordination with EDQM •
Development and review of pharmacopoeial monographs and general chapters and notices (including PAs, essential oils, assay methods). Action: On-going activity, selection and discussion of relevant topics for the HMPC via participation of an EDQM representative in Q DG meetings and Q DG Observers at Ph. Eur. expert groups 13A, 13B and TCM. Q DG observers: M. Brum or I. Chinou/HMPC (13A), B. Kroes (13B), R. Länger (TCM); EDQM observer at Q DG: M. Bald
•
Involvement in and contribution to Certification of herbal active substances in view of MA and registration procedures for (traditional) herbal medicinal products. Action: (1) Compile a list of issues in relation to the use of CEP in applications for (T)HMPs (2) Propose amendments / clarifications on the use of CEP in the existing quality guidance documents where appropriate (3) Prepare as appropriate HMPC comments on the established CEP procedure for herbal active substances with emphasis on (the suitability of) the information that is made available on a CEP. Support the development of new and the revision of existing CEP Guidance documents.
5. General •
Provide input to general quality guidelines and other guidance documents applicable to herbal substances/preparations/medicinal products. Action: On-going activity, monitor QWP activities and draft/ propose to HMPC input as necessary.
•
Provide input on quality questions for herbal medicinal products in the framework of HMPC coordination with other EMA committees/working parties (e.g. SA procedures with SAWP) if required.
Work plan for the HMPC Quality Drafting Group (Q DG) 2017 EMA/HMPC/114746/2017
Page 2/3
•
HMPC Assessors training on quality of herbal medicinal products. Action: Propose specific topic to HMPC for assessors training 2nd half 2017 and in liason with EMA secretariat identify speakers and support organisation.
Work plan for the HMPC Quality Drafting Group (Q DG) 2017 EMA/HMPC/114746/2017
Jan 25, 2018 - 30 Churchill Place â Canary Wharf â London E14 5EU â United Kingdom. An agency of ... 2. Guidelines. Note: The ExcpDG reviews the safety information of individual excipients (update of an excipient of the ... version of the annex
Jan 30, 2018 - HMPC work plan. EMA/HMPC/150152/2018. Page 2/7. Evaluation activities for herbal medicinal products as defined in Reg. (EC) No 726/2004 and Dir. 2001/83/EC. 1.1. Establishment and update of EU herbal monographs and list entries. Activi
Jan 25, 2017 - Also in June 2016, EMA's multiannual work programme to 2020 was published, .... of the workshops organised in 2016 on social media, mHealth/apps (IMI- ... Follow the outcome of the social media workshop held in 2016, ...
Jan 25, 2017 - In June 2016 the PCWP started its new mandate for the period .... Follow the outcome of the workshops organised in 2016 on social media, mHealth/apps (IMI- ... Follow the outcome of the social media workshop held in 2016, ...
EMA/CVMP/SWP/278493/2017. Committee for Medicinal Products for Veterinary Use (CVMP). Work plan for the CVMP Safety Working Party (SWP-V). 2018. Chairpersons. Status. Chair: E. Lander Persson. Vice-chair: S. Scheid. Adopted by CVMP in December 2017.
Jan 26, 2017 - different aspects, or if these aspects call for the development of new ... Joint EMA Symposium in the margins of the CEN-ISBS conference, ...
Jan 31, 2018 - Activities in 2018. PRAC activities to achieve the objectives set for this area: â¢. Review of lessons learnt from the pilot regulatory network study involving EMA, Spain and the United Kingdom, as a source of learnings for regulatory
Feb 15, 2017 - Improve the quality of initial orphan designation applications by ... Maintenance ... Development of strategies to implement recommendations ...
Apr 12, 2017 - Member. Marc Turner. Scottish National Blood Transfusion. Service .... CAT will collaborate with the BWP and the HMA innovation network on this ... 1.3.3. Addressing the Environmental Risk assessment of ATMPs containing.
Jan 27, 2017 - 30 Churchill Place â Canary Wharf â London E14 5EU â United Kingdom. An agency of the European Union. Telephone +44 (0)20 3660 .... best available scientific expertise in the Network and ensure that paediatric information related
Dec 15, 2016 - Work plan for the Radiopharmaceutical Drafting Group for. 2017. Chairperson: Anabel Cortes Blanco. Status of the work plan: Adopted in ...
Dec 14, 2017 - Send a question via our website www.ema.europa.eu/contact ... ad-hoc to respond to time-sensitive requests on products and to progress guidelines, as required. 2. Guidelines. 2.1. New EU Guidelines ... Recommendation to the CAT on data
Dec 8, 2016 - Application of the 3Rs in Regulatory Testing of Medicinal Products (3R's) .................. 9 ... intended to stimulate development of new veterinary medicines for minor species and/or for rare diseases in .... throughout their lifecyc
Jan 12, 2017 - to develop new, and revise existing document such as EMA GCP inspection ... trends to be followed in the period 2017-2018; ... in MS, in third countries and inspections conducted in the framework of an application for a.
Jan 25, 2018 - Some documents mentioned in the agenda cannot be released at present following a request for access to documents within the framework of Regulation (EC) No 1049/2001 as they are subject to on- going procedures for which a final decisio
Jun 5, 2018 - Some of the information contained in this agenda is considered ... access to documents within the framework of Regulation (EC) No 1049/2001 ...
The tasks identified by the Committee should be included in the work programme of each working party to be adopted by the HMPC. The Working Party on ...
Dec 7, 2017 - by the European Medicines Agency (EMA or the 'Agency') in 1999. The incident ... Factors that could trigger an incident or a crisis may include newly published data in scientific journals, coverage in the lay .... European Centre for Di
5 days ago - Guidelines should include more details on the principles of good information design in which content and layout are ... relevance and importance of the QRD template is also acknowledged in this respect as it is the main tool .... databas
Jun 23, 2017 - 6.1.2. Business process changes and resourcing requirements . ..... It is suggested that all impacted organisations should prepare plans ..... formats and the interface has been updated to the new software ... nullified if the pre-exis
Jan 31, 2017 - E-mail [email protected] Website www.ema.europa.eu ... 1) For new initial marketing authorisation (MA) applications via the centralised ...
